Innovating.works Conecta tu I+D

Showing 1 to 20 of 67 results

DarChemDN: Darwinian Chemistry Doctoral Network ELVESYS participó en un HORIZON EUROPE: HORIZON-MSCA-2022-DN-01 Darwinian evolution is unrivalled in its ability to invent, which Humankind has already exploited for various purposes such as plant and ani...
2023-07-06 - 2027-10-31 | Financiado

GALILEO: The first wide range flow sensor to unlock microfluidic cell analyses for preclinical studies ELVESYS tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 There is a critical need to improve the diagnosis, drug discovery and development pipeline to increase the success rate of new therapeutics...
2023-03-28 - 2025-04-30 | Financiado

THOR: building vascular networks and Blood-Brain-Barriers through a Biomimetic manufacturing Technology fo... ELVESYS participó en un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDEROPEN-01 Tenths of millions of people with organ failures or suffering from degenerative diseases are waiting for a novel cellular therapy or for a t...
2022-12-22 - 2026-12-31 | Financiado

BioProS: Biointelligent Production Sensor to Measure Viral Activity ELVESYS participó en un HORIZON EUROPE: HORIZON-CL4-2021-DIGITAL-EMERGING-01 We aim to transform virus biomanufacturing processes and enable new quality control strategies by a continuous, real-time capable biohybrid...
2022-06-23 - 2026-06-30 | Financiado

LIFESAVER: Living Impact on Fetal Evolution Shelter Analyze Validate Empower Regulations ELVESYS participó en un H2020: H2020-LC-GD-2020 In Europe about 75% of all neonatal deaths and 60% of all infant deaths occur in infants born preterm, and worldwide 450 neonatal deaths occ...
2021-09-28 - 2025-10-31 | Financiado

ALTERNATIVE: environmentAL Toxicity chEmical mixtuRes through aN innovative platform based on aged cardiac tissue... ELVESYS participó en un H2020: H2020-LC-GD-2020 ALTERNATIVE will develop an innovative platform able to detect the cardiotoxicity of chemicals and their bio-transformation products. The no...
2021-09-02 - 2025-03-31 | Financiado

Tumor-LN-oC: Tumor and Lymph Node on Chip for cancer studies ELVESYS participó en un H2020: H2020-NMBP-TR-IND-2018-2020 The lymphatic system and lymph nodes (LNs) are an integral part of our adaptive immune system and many tumors exploit lymphatic vessels to s...
2020-11-06 - 2025-10-31 | Financiado

Micro4Nano: Multifunctional nanocarriers for nonlinear microscopy new tools for biology and medicine ELVESYS participó en un H2020: H2020-MSCA-RISE-2020 The direct 3D visualization of large sections of biological tissues, made possible by multiphoton microscopy, has the potential to revolutio...
2020-11-05 - 2026-09-30 | Financiado

BIOALL: Biomass and CO2 valorisation to high value added chemicals ELVESYS participó en un H2020: H2020-MSCA-RISE-2020 BIOALL falls in the topics of fighting climate change, circular economy and clean energy through the development of efficient low-cost proce...
2020-10-23 - 2026-08-31 | Financiado

LasIonDef: Training on Laser Fabrication and Ion Implantation of Defects as Quantum Emitters ELVESYS participó en un H2020: H2020-MSCA-ITN-2020 LasIonDef will establish an effective and innovative network delivering high level training in integrated quantum photonic and microfluidics...
2020-08-31 - 2025-01-31 | Financiado

NeuroTrans: NEUROtransmitter TRANSporters from single molecules to human pathologies ELVESYS participó en un H2020: H2020-MSCA-ITN-2019 The vision of the ETN network NeuroTrans (NEUROtransmitter TRANSporters: from single molecules to human pathologies) is to (i) enable an imp...
2020-02-05 - 2024-07-31 | Financiado

FIDA: Scale up of our disruptive antibody analytical platform based in flow induced dispersion analysis F... ELVESYS participó en un H2020: H2020-EIC-FTI-2018-2020 Therapeutic antibodies have rapidly become a major component of modern medicine. The global research antibodies market size is expected to r...
2019-11-05 - 2022-05-31 | Financiado

ElectroMed: Electrochemically enabled high throughput peptidomics for next generation precision medicine ELVESYS participó en un H2020: H2020-FETOPEN-2018-2020 The uptake of proteomics for precision or personalised medicine applications requires the development of an effective screening instrument c...
2019-09-03 - 2023-12-31 | Financiado

EUROVA: European Oocyte Biology Research Innovation Training Net ELVESYS participó en un H2020: H2020-MSCA-ITN-2019 The hallmark of successful mammalian reproduction is the fusion between a haploid spermatozoon and a metaphase II oocyte. The generation of...
2019-08-12 - 2024-10-31 | Financiado

ENHPATHY: Molecular basis of human enhanceropathies ELVESYS participó en un H2020: H2020-MSCA-ITN-2019 Mutations within coding genes have traditionally been considered the major genetic cause of human disease. However, it is becoming increasin...
2019-08-09 - 2024-02-29 | Financiado

ActiveMatter: Active Matter From Fundamental Science to Technological Applications ELVESYS participó en un H2020: H2020-MSCA-ITN-2018 During the last decade, active matter has been attracting increasing interest because its study can shed light on far-from- equilibrium phys...
2019-05-10 - 2024-02-29 | Financiado

CAR-OAC: Carotid artery on a chip device to model thromboembolisms induced by vascular lesions and perform dr... ELVESYS tramitó un H2020: H2020-MSCA-IF-2018 This project will be focused on designing a microfluidic device to visualize haemodynamics within a carotid-artery mimetic device. The syste...
2019-04-15 - 2022-02-16 | Financiado

MAHT-FunSST: Microfluidic Approaches for High Throughput Fungicide Screening and Sensitivity Testing ELVESYS tramitó un H2020: H2020-MSCA-IF-2018 Fungicide development and screening is stuck in an innovation gap, in which it incurs staggering expenses and takes many years to get a fung...
2019-04-02 - 2021-04-23 | Financiado